Real-world studies of vaccines aren't directly comparable with clinical trials, but their results are still good news.
Fair global agreements, home-grown vaccines and sharing extra doses with poorer nations are all needed if we're to ever emerge from this pandemic.
Though COVID-19 has killed Black Americans at nearly twice the rate as white Americans, Black people are the least likely racial group to say they're eager to get the vaccine.
A waiver may not allow all developing countries to secure medicines and other anti-COVID technologies in a timely way.
In 1959, three armed men broke into the University of Montréal and stole the whole supply of polio vaccine — 75,000 vials valued at $50,000. What have we learned from this event?
Plus new research on why China is closing down coal-fired power stations. Listen to episode 3 of The Conversation Weekly.
The clock starts ticking once the vaccine leaves the freezer. Here's what to expect.
The Pfizer vaccine rolls out to high-risk people in Australia from next week. And many of these front-line workers will be women. Here's what we know so far.
The world's most advanced economies will incur half the total costs associated with a failure to vaccinate poorer nations, which could exceed $4 trillion if only half their citizens are inoculated.
We can help vaccines keep up with the mutating coronavirus by doubling down on preventive measures.
Women, particularly those of childbearing age, were more likely to be unsure about getting vaccinated.
Vaccine selfies are just the tip of the iceberg of doctor frustration over Canada's fragmented vaccine rollout.
Researchers are already working to improve the current crop of mRNA vaccines. Hopefully this will help them become more practical and affordable for the entire world, not just first-world countries.
The approval of the first of four COVID-19 vaccines marks the first step in New Zealand's plans for a Pacific-wide immunisation rollout.
The conflict shows just how high the political stakes are on all sides.
With slow vaccine distribution and manufacturing, some people won't get the second dose on time. But does it matter?
Historically, we immunized children against diseases like polio that were a clear danger to them, but COVID-19 is usually mild in children. However, herd immunity is unlikely without vaccinating kids.
It’s unlikely South Africa will have a substantial number of vaccines until the second half of this year. Most of the vaccines produced in Europe or America have been bought by other countries.
The shipment of goods to suppliers has become technologically sophisticated. Delays in getting out the COVID-19 vaccine to people show that the breakdowns come down to something more basic.
Now that two COVID vaccines have been authorized by the FDA, questions arise. Today, a physician from Indiana University School of Medicine answers five reader questions.